Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Women Undergoing Adjuvant Chemotherapy for Stage I, II, or III Breast Cancer
NCT00022386Phase 4Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Modality
- Biologic, rProtein (Recombinant Protein)
01
Overview
A Phase 4 trial of epoetin alfa in anemia, sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00022386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00022386.